Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2024 16:30 ET | Source: Cardiff Oncology, Inc.

Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC

- Findings underscore that the combination of onvansertib with FOLFIRI and bevacizumab demonstrates clinical activity and is well tolerated in second-line KRAS-mutant mCRC - - Post hoc analysis...
July 16, 2020 07:27 ET | Source: Liteye Systems, Inc.

Liteye C-AUDS Chosen to Defend Critical Infrastructure by the US Government

Centennial, Colorado, July 16, 2020 (GLOBE NEWSWIRE) -- Centennial, Colo. (July 15, 2020) — Liteye Systems, Inc., is pleased to announce the selection of its Containerized Anti-UAS Defense Systems...